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Abstract
BACKGROUND: Androgen (AR) and Estrogen (ER) hormones play an important role in the prenatal and postnatal 
development of the urogenital tract and especially the penis. Growth factors also influence the development of genital 
structures. Little is known about the exact role of Mastermind Like Domain 1 (MAMLD1) in sexual development. A 
role in sex differentiation through supporting testosterone production in critical periods of male development has 
been suggested. MAMLD1 mutations result in hypospadias with and without a disorder of sexual development (DSD) 
primarily because of compromised testosterone production around the critical period for fetal sex development, but 
the underlying etiology remains unclear. 
AIM: The objective of this study was to investigate the correlation between gene factor MAMLD1, AR, ER1, and ER2 
with the incidence of hypospadias.
OBJECTIVE: The objective of this study was to investigate the correlation between gene factor MAMLD1, AR, ER1, 
and ER2 with the incidence of hypospadias.
METHODS: From 2017-2018, peri-urethral dartos were harvested from 46 patients with proximal hypospadias, 24 
patients with distal hypospadias and 10 patients with normal penile were used as controls. The expressions of 
MAMLD1, AR, ER1, and ER2 were investigated by one-step quantitative polymerase chain reaction.
RESULTS: Median age was 5 years old in the 70 patients with hypospadias and 6 years old in the control subjects. 
Total specimens taken included 24 distal penile, 46 proximal penile, and 10 normal penile specimens. We found 
decreasing MAMLD1 and AR expressions, but ER2 expression increased in patients with hypospadias compared to 
controls, which was statistically significant (p < 0.001). A positive correlation between MAMLD1 and AR was found in 
patients with hypospadias (r = 0.062; p = 0.038).
CONCLUSIONS: Decreasing of MAMLD1 and AR expression was followed by increasing ER2 expression in patients 
with hypospadias. MAMLD1 had a positive correlation with AR so the defect of MAMLD1 may influence AR and 
increase the incidence of hypospadias.
Edited by: https://publons.com/researcher/391987/
mirko-spiroski/
Citation: Yuri P, Heriyanto DS, Rodjani A, Hutasoit YI, 
Hutahaean AYA, Rahman MR, Amanda RR, Raksawardana 
YK, Lestari RP, Fardilla FP, Wahyudi I. Expression of mRNA 
Mastermind-like Domain-Containing 1, Androgen Receptor, 
and Estrogen Receptor in Patients with Hypospadias. Open 
Access Maced J Med Sci. 2020 Aug 20; 8(A):543-547. 
https://doi.org/10.3889/oamjms.2020.4557
Keywords: Hypospadias; Mastermind-like domain 1; 
Androgen receptor; Estrogen receptor
*Correspondence: Prahara Yuri, Division of Urology, 
Department of Surgery, Faculty of Medicine, Public 
Health and Nursing, Universitas Gadjah Mada, Dr. 
Sardjito Hospital, Jl. Kesehatan No. 1, Yogyakarta 55281 
Indonesia. E-mail: prahara.yuri@ugm.ac.id
Received: 04-Mar-2020
Revised: 04-Jul-2020
Accepted: 30-Jul-2020
Copyright: © 2020 Prahara Yuri, Didik Setyo Heriyanto, 
Arry Rodjani, Yonas Immanuel Hutasoit, 
Andre Yudha Alfanius Hutahaean, 
Muhammad Ridhaniar Rahman, Reisya Rizki Amanda, 
Yusuf Kirana Raksawardana, Rahmadani Puji Lestari, 
Firly Putri Fardilla, Irfan Wahyudi
Funding: Dana Masyarakat (DAMAS) FKKMK-UGM 2018.
Competing Interests: The authors have declared that no 
competing interest exists.
Open Access: This is an open-access article distributed 
under the terms of the Creative Commons Attribution-
NonCommercial 4.0 International License (CC BY-NC 4.0)
Introduction
Hypospadias is a relatively common genital 
anomaly in humans in which the urethral opening is not 
correctly positioned at the tip of the penis. Its prevalence 
in many countries ranges from 4 to 43 cases per 
10,000 births  [1]. This congenital disorder is the second 
most common in boys after cryptorchidism and the most 
frequent malformation of the penis [2]. Hypospadias is 
defined as a malformation of the penis due to incomplete 
development of the male urethra leading to the localization 
of the urinary meatus on the ventral side of the penis in a 
variable position from the glans to the perineum [3], [4]. 
The precise etiology remains unclear in most disorder of 
sexual development (DSD) cases including hypospadias. 
Several candidate genes and their response to 
environmental agents have been analyzed both in human 
and mouse tissues, opening many promising areas of 
research concerning the etiology of hypospadias [5].
Mastermind-like domain-containing 1 
(MAMLD1, previously known as CXORF6) is an 
X-linked transcriptional coactivator [6]. It is expressed in 
Sertoli and Leydig cells of fetal mice around the critical 
period for sexual development [7]. MAMLD1 is known 
to be implicated in various human DSDs, including 
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hypospadias. MAMLD appears to regulate testosterone 
production around the critical period for sex development 
[8]. However, the underlying mechanism of hypospadias’ 
pathogenesis due to MAMLD1 is poorly understood.
Several genes may affect the anomalies of 
male development such as androgen receptors (AR) 
and estrogen receptors (ER). The previous studies 
report that several mutations specifically affect AR 
synthesis in the testis which can lead to hypospadias. 
Several studies reported hemizygous mutations (as 
AR is X-linked) in patients with hypospadias [9]. ER 
dysfunction may also contribute to the pathogenesis 
of hypospadias. Various homozygous mutations have 
been reported to cause hypospadias and cryptorchidism 
in the 46 XY sibling [10]. As previously reported, 
there are two ER receptors, ER1 and ER2, which 
interact to form homo-heterodimer ER complexes. ER 
bound by ER translocates to the nucleus to activate 
ER-responsive genes. ER1 and ER2 are expressed in 
most cells of the male urethra [11]. This study examined 
the interaction between MAMLD1, AR, ER1, and ER2 
in the development of hypospadias. We compared 
the expression levels of MAMLD1, AR, ER1, and ER2 
between normal boys and those with hypospadias.
The objective of this study was to investigate 
the correlation between gene factor MAMLD1, AR, 
ER1, and ER2 with the incidence of hypospadias.
Methods
Patients
Seventy patients underwent repair of hypospadias 
without DSD and 10 normal patients who underwent 
circumcision as controls in four pediatric urology centers 
from 2017 to 2018. We divided the samples into distal 
hypospadias, proximal hypospadias, and controls. We 
used periurethral dartos obtained during chordee excision 
following the standard procedure using samples from 
RNAlater fixation. The surgical approach of each patient 
was decided depending on the patient’s condition with 
distal hypospadias treated by tubularized incision plate, 
or Mathieu onlay island flap urethroplasty, and proximal 
hypospadias using Duckett, two-stage urethroplasty.
 Polymerase chain reaction (PCR) analysis
All foreskin tissues of the patients were 
pooled in a single tube. Total RNA was extracted from 
a homogenized sample using the Hybrid-RTM Isolation 
Kit and cDNA was synthesized from 200 ng of total 
RNA using NEXproTM quantitative reverse transcription 
(qRT)-PCR kit. Quantitative PCR was performed for 
MAMLD1, AR, ER1, and ER2. We used GAPDH as 
internal control, Table 1.
Amplification conditions consisted of an initial 
denaturation step at 95°C for 10 min, followed by 
40 cycles at 95°C for 20 s, at 56°C for 40 s, and at 
72°C for 60 s. An extension was carried out at 72°C for 
5 min. The quantitative qPCR amplified samples were 
analyzed by the BiONEER ExicycleTM 96 (BioNEER, 
Daejeon, South Korea).
Statistical analysis
Differences with statistical significance were 
determined using one-way ANOVA test or Kruskal–
Wallis test, and Mann–Whitney U-test was used to 
compare differences between groups. P values < 0.05 
were considered as statistically significant.
Table 1: MAMLD1, AR, ER1, ER2, and GADPH primers
Gen Forward primer Reverse primer
MAMLD1 TTTGCAACTCCAGCATCATC CCTAACTCCTTCCCCTGGAC
AR CCTGGCTTCCGCAACTTACAC GGACTTGTGCATGCGGTACTCA
ER1 ATTTCTCTGCGCCCCTAGAC CATAGTGGTACCCAGACGCA
ER2 TGAACTGGGCCCAGACTATG ATGGTACCCTGAGGCGTAGT 
GADPH 5’-GCATCCTGGGCTACACTGAG-3’ 5’-TCCACCACCCTGTTGCTGTA-3’
AR: Androgen, ER: Estrogen, MAMLD1: Mastermind-like domain 1.
Results
Periurethral dartos was harvested from 
46 patients with proximal hypospadias, 24 patients with 
distal hypospadias during urethroplasty, and 10 patients 
with normal penile during circumcision as controls. 
Characteristic data of patients are presented in Table 2.
Table 2: Variable characteristics
Variables Value
Age, year 5 (1-14)
Hypospadias type, n (%)
Distal 24 (30)
Glandular 5 (6.3)
Subcoronal 2 (2.5)
Distal penile 2 (2.5)
Midshaft 14 (17.5)
Proximal penile 1 (1.3)
Proximal 46 (57.5)
Penoscrotal 33 (41.3)
Scrotal 12 (15.0)
Perineal 1 (1.3)
Control 10 (12.5)
MAMLD1, median (min-max) 4.59 (1.86–10.55)
AR, Mean (SD)* 6.84 ± 2.57
ER1, Median (min-max) 14.92 (4.59–39.39)
ER2, Mean (SD)* 21.89 (8.14)
Hypospadias characteristics penile torsion, n (%)
Yes 4 (5.7)
No 66 (94.3)
Penile curvature, n (%)
Mild (<30 degrees) 22 (31.4)
Moderate (30–60 degrees) 14 (20)
Severe (>60 degrees) 34 (48.6)
Urethral plate, n (%)
Narrow (<8mm) 36 (51.4)
Wide (≥8 mm) 34 (48.6)
Penoscrotal transposition
Yes 9 (12.9)
No 61 (87.1)
Bifid scrotum
Yes 10 (14.3)
No 60 (85.7)
Urethroplasty
First urethroplasty 47 (67.1)
Redo-urethroplasty 23 (32.9)
*Kolmogorov–Smirnov p>0.05; AR: Androgen, ER: Estrogen, MAMLD1: Mastermind-like domain 1, 
SD: Standard deviation, VEGF: Vascular endothelial growth factor.
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The quantitative PCR analyses showed 
significantly decreased MAMLD1 expression in both distal 
(5.33 ± 2.21) and proximal (4.82 ± 2.42) hypospadias 
compared with the control group (9.55 ± 0.93) (p < 0.05). 
Meanwhile, the expression of the AR showed decreases 
in both distal (5.33 ± 2.21) and proximal (4.82 ± 2.42) 
hypospadias compared to the control group (9.55 ± 
0.93) with significant difference (p < 0.05). In line with the 
result of MAMLD1 expression, ER1 showed decreasing
Table 3: Compared mean analysis among the groups
Variable Proximal hypospadias Distal hypospadias Control p
MAMLD1# 4.82 (± 2.42) 5.33 (± 2.21) 9.55 (± 0.93) <0.001
AR* 6.52 (± 2.61) 6.27 (± 2.18) 9.69 (± 1.10) <0.001
ER1# 15.31 (± 6.49) 17.93 (± 8.22) 12.82 (± 2.23) 0.158
ER2* 24.44 (± 8.41) 21.22 (± 5.38) 11.79 (± 2.49) <0.001
#Kruskal–Wallis, *one-way ANOVA. AR: Androgen, ER: Estrogen, MAMLD1: Mastermind-like domain 1.
expression in both hypospadias types, with proximal 
(15.31 ± 6.49) and distal (17.93 ± 8.22) compared to 
the control group (12.82 ± 2.23). Reciprocally with 
ER1 and ER2 showed increasing expression in both 
hypospadias types, with proximal (24.44 ± 8.41) and 
distal (21.22 ± 5.38) compared to the control group 
(11.79 ± 2.49) (Table 3 and Figure 1).
Figure 1: Expression of MAMLD1, androgen receptor, estrogen 
receptor 1, and estrogen receptor 2 in patients with hypospadias 
compared to the control group. AR: Androgen, ER: Estrogen, 
MAMLD1: Mastermind-like domain 1,*statistically significant
Post hoc analyses were used to explore which 
group was significantly related. It was revealed that there 
were significant differences in the MAMLD1, AR, and ER2 
hypospadia groups (both distal and proximal) compared 
with the control group, while among hypospadias types, 
there were no significant differences (Table 4).
Table 4: Post hoc analysis
Variable dependent Hypospadias type p 95% CI
Lower Upper
MAMLD1# Distal Proximal 0.l99 N/A N/A
Distal Control <0.001 N/A N/A
Proximal Control <0.001 N/A N/A
AR* Distal Proximal 1.00 −1.69 1.21
Distal Control <0.001 −5.59 −1.26
Proximal Control <0.001 −5.19 −1.17
ER1# Distal Proximal 0.195 N/A N/A
Distal Control 0.059 N/A N/A
Proximal Control 0.121 N/A N/A
ER2* Distal Proximal 0.230 −7.60 1.17
Distal Control 0.002 2.87 15.98
Proximal Control <0.001 6.56 18.72
#Mann–Whitney, *Bonferroni, CI: Confidence interval, AR: Androgen, ER: Estrogen, MAMLD1: Mastermind-
like domain 1.
Linear regression analysis of each of the mRNA 
expressions showed the AR expression and MAMLD1 
expression had strong correlation (r = 0.062) and the 
positive pattern indicates that the more MAMLD1 
expression is reduced, the AR expression will also 
decrease. Furthermore, the post hoc results showed 
a significant association between AR expression and 
MAMLD1 expression with p = 0.038 (Table 5).
Discussion
The etiology of hypospadias cases, however, 
is not yet solved. Genes or environmental factors may 
play a principal role in the pathogenesis of hypospadias. 
Hypospadias can be equally transmitted through 
the maternal and paternal sides of the family and 
recurrence risks for brothers and sons of hypospadias 
cases are similar [12]. Various genes are known to 
be implicated in testes development, masculinization, 
and hypospadias such as MAMLD1, AR, ER1, and 
ER2. Mutations that affect the ability of the gonads to 
produce these hormones or the cell’s sensitivity to these 
hormones can result in anomalies of male development 
including hypospadias [6].
MAMLD1 (previously known as CXorf6) located 
on human chromosome Xq28 is a causative gene for 
hypospadias, a mild form of 46, XY DSD [13]. At present, 
multiple mutations have been reported in patients with 
various types of hypospadias [13], [14], [15]. In this regard, 
the mouse homologous gene MAMLD1 is transiently 
expressed in fetal Sertoli and Leydig cells around the critical 
period for sex development [13], and transient MAMLD1 
knockdown using small interfering RNAs (siRNAs) reduces 
testosterone production in cultured mouse Leydig tumor 
cells (MLTCs) [13]. Various mutations affect the expressions 
of MAMLD1 in patients with hypospadias. They were 
downregulated compared to the control group. These 
findings are similar with other studies which stated that the 
mRNA level of MAMLD1 was severely reduced (25–30%) 
in the MLTCs with reduction in testosterone production 
(50–60%) [8]. This association between testosterone 
production and expression of MAMLD1 is consistent with 
the hypospadias phenotype in the affected patients [16].
ARs affect and play an important role in 
the prenatal and postnatal development of the 
urogenital tract, especially the penis [17]. The present 
study showed a decrease in the expression of the 
AR in patients with hypospadias compared to the 
control group. Decreased AR expression may be 
affected by elevation in the number of CAG repeats. 
The relationship between CAG repeats and AR 
transcriptional activity has not been well explored. The 
AR gene is composed of eight exons and is located on 
the X chromosome at q11-q12. Exon 1 of the AR gene 
contains a polymorphic sequence of CAG repeats, 
which usually varies in number from 10 to 35, which 
encodes polyglutamine stretches of AR transactivation 
domain [18], [19]. Many findings suggest that the CAG 
number is negatively correlated with AR transcriptional 
activity [20]. In fact, patients affected by Kennedy 
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syndrome have a number of CAG repeats >40 together 
with decreased virilization, reduced sperm production, 
testicular atrophy, and infertility [18]. Repeat length 
is positively affecting AR transcriptional activity in 
skeletal muscle, while the opposite appears in prostate 
cells. It is possible that alterations of the repeat length 
induce conformational changes in the AR N-terminal 
domain that enhance or suppress transcriptional 
cofactor and AR-associated protein interactions [21]. 
Other studies have shown that ethnic differences 
in CAG repeat length of the AR gene exist between 
African, Caucasian, and Asian populations. The allele 
expansion found in Africans is between 18 and 20 
repeats, although some African subpopulations seem 
to have a shorter track [22]. In contrast, Caucasian 
and Asian populations have a longer expansion, 
where the mean number of CAG repeats is 21–22 in 
Caucasians [20] and 23 in Asians [23].
This research also found a positive correlation 
between MAMLD1 and AR. The result of our study 
showed a decreased in expression MAMLD1 similar to 
the expression AR which has decreased. It is known that 
defects in the AR function and its regulatory mechanisms 
contribute to the development of hypospadias [24].
Several studies showed that the expressions 
of ER and AR can also influence the development 
of male external genitalia [11], [25], [26], [27], [28]. 
Our study found that both ERs, including ER1 and 
ER2, have elevated expression compared to the 
control group. These findings show a counterbalance 
between AR and ER. Dominant expression of ER 
receptors in the penile tissues of children with 
hypospadias and the theory of disrupted AR and ER 
receptors interaction and/or balance could play a 
role during the development of external genitalia in 
patients with hypospadias [17]. Reduced testosterone 
levels and elevated ER levels may also be a risk 
factor for hypospadias [6], [29]. Interestingly, there 
were no studies that definitively stated that endocrine 
disruptors caused hypospadias. However, there were 
multiple studies that implicated endocrine disruptors 
as one component of a multifactorial model for 
hypospadias.
One limitation of this study is the nature of the 
cross-sectional study that does not include following the 
possibility of changes of the expression ER2 overtime. 
However, as far as we know, this is the first study that 
discussed about ER2 and its role in hypospadias in an 
Asian population.
Conclusions
Decreasing MAMLD1 and AR expressions were 
followed by increasing ER2 expression in hypospadias 
patients. MAMLD1 had a positive correlation with AR so 
the defect of MAMLD1 may influence AR and increase 
the incidence of hypospadias.
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